“This case is very concerning for a number of reasons,” says Rick Bright, an American immunologist and vaccine researcher and a U.S. government health official from 2016 to 2020. “It’s in an otherwise healthy teenager. Like a similar case in Missouri, there’s no clear source for infection and no direct farm connection.”
New findings from two studies have tied use of the antiviral drug nirmatrelvir-ritonavir (Paxlovid) to a reduction in COVID-19 hospitalizations and death, as well as to faster resolution of symptoms and less use of healthcare resources.
As H5N1 bird flu continues to spread around the US, health officials recently found that 7 percent of dairy workers tested on farms in two states had evidence of recent infection — and some had signs of infection even when they didn’t feel sick.
While long COVID is not usually immediately or directly life-threatening, it’s possible it could exacerbate existing conditions, and play a role in a person’s death in this way.
Seasonal influenza epidemics impose substantial burdens on health care systems and cause >5 million hospitalizations of adults each year. The current approach to influenza vaccine development requires comprehensive surveillance of circulating strains, which are constantly moving from continent to continent....
Recent Comments